Status:
UNKNOWN
Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum Repair
Lead Sponsor:
The Cooper Health System
Collaborating Sponsors:
New Jersey Health Foundation
Conditions:
Postoperative Pain, Acute
Opioid Use
Eligibility:
All Genders
15-25 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if patients age 15 to 30 years old being treated for shoulder labrum repair and SLAP lesions have significant differences in pain levels postoperatively when ...
Detailed Description
The opioid crisis has illuminated the risks of opioid use for pain management, with renewed interest in reducing opioid consumption after common orthopedic procedures. Anti-inflammatory medication is ...
Eligibility Criteria
Inclusion
- Patients between the ages of 15 - 25 years old
- Patients with a diagnosis of a labrum tear who will undergo surgical intervention
Exclusion
- Patients under the age of 14 years old
- Patients age 26 years or older
- Patients with a nonoperative diagnosis of a labrum tear
- Patients who elect not to undergo surgical treatment
- Patients who are on opioid medications preoperatively
Key Trial Info
Start Date :
December 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05974423
Start Date
December 16 2022
End Date
December 1 2025
Last Update
August 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cooper University Hospital
Camden, New Jersey, United States, 08103